Stocks and Investing
Stocks and Investing
Wed, November 16, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, November 15, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Erin Wright Maintained (XRAY) at Buy with Decreased Target to $39 on, Nov 15th, 2022
Erin Wright of Morgan Stanley, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Buy with Decreased Target from $42 to $39 on, Nov 15th, 2022.
Erin has made no other calls on XRAY in the last 4 months.
There are 2 other peers that have a rating on XRAY. Out of the 2 peers that are also analyzing XRAY, 1 agrees with Erin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $41 on, Thursday, July 21st, 2022
This is the rating of the analyst that currently disagrees with Erin
- John Kreger of "William Blair" Downgraded from Hold to Sell on, Friday, August 5th, 2022
Contributing Sources